DARATUMUMAB\HYALURONIDASE-FIHJ for Plasma cell myeloma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 1,092 adverse event reports in the FDA FAERS database where DARATUMUMAB\HYALURONIDASE-FIHJ was used for Plasma cell myeloma.
Most Reported Side Effects for DARATUMUMAB\HYALURONIDASE-FIHJ
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Product dose omission issue | 189 | 7.4% | 0 | 10 |
| Dyspnoea | 112 | 4.4% | 9 | 50 |
| Off label use | 109 | 4.3% | 9 | 18 |
| Fatigue | 101 | 4.0% | 3 | 30 |
| Pyrexia | 86 | 3.4% | 3 | 44 |
| Nausea | 80 | 3.2% | 2 | 33 |
| Pneumonia | 78 | 3.1% | 8 | 59 |
| Plasma cell myeloma | 74 | 2.9% | 13 | 9 |
| Diarrhoea | 71 | 2.8% | 6 | 27 |
| Neutropenia | 70 | 2.8% | 5 | 16 |
| Infusion related reaction | 66 | 2.6% | 6 | 28 |
| Rash | 65 | 2.6% | 0 | 9 |
| Chills | 63 | 2.5% | 0 | 12 |
| Neuropathy peripheral | 62 | 2.4% | 2 | 10 |
| Death | 61 | 2.4% | 61 | 9 |
Other Indications for DARATUMUMAB\HYALURONIDASE-FIHJ
Product used for unknown indication (930)
Primary amyloidosis (44)
Amyloidosis (31)
Plasma cell myeloma refractory (19)
Plasma cell myeloma recurrent (10)
Other Drugs Used for Plasma cell myeloma
LENALIDOMIDE (273,951)
POMALIDOMIDE (81,096)
DEXAMETHASONE (49,067)
BORTEZOMIB (31,567)
DARATUMUMAB (19,119)
IXAZOMIB (17,602)
CARFILZOMIB (15,333)
THALIDOMIDE (10,689)
CYCLOPHOSPHAMIDE (9,148)
REVLIMID (7,122)